Back to top

Psychedelic: Compass Pathways reports six-month data for psilocybin drug

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study results, drug delivery eval...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AtaiBeckley Inc (ATAI)

COMPASS Pathways PLC Sponsored ADR (CMPS)

Definium Therapeutics, Inc. (DFTX)

Cybin Inc. (HELP)